Newsletter
Carbonic Anhydrase IX (CA IX): Acid-Base Regulator and Driver of Tumorigenesis
Carbonic anhydrase IX (CA IX) is a transmembrane, hypoxia-induced zinc metalloenzyme that converts carbon dioxide to bicarbonate and protons...
Newsletter
A Rising StAR in Cancer Research
Steroidogenic acute regulatory protein 1 (StAR/StARD1) mediates the rate-limiting step in steroidogenesis...
Newsletter
NEK7: An Essential Regulator of NLRP3 Inflammasome Activation
NEK7: An Essential Regulator of NLRP3 Inflammasome Activation
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Newsletter
Lateral Flow Assay for Influenza & SARS-CoV-2 Viruses Detection
Influenza A & B Virus Antibodies (IVD grade)
Literature
Brochure - Cited Antibodies
Download the latest version of GeneTex's Cited Antibodies brochure.
Newsletter
New Therapeutic Paradigm for Cancers with Activated NRF2
New Therapeutic Paradigm for Cancers with Activated NRF2
Literature
Flyer-Cancer
Download the latest version of GeneTex's Cancer flyer.
Newsletter
GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]
GeneTex's RAS (G12D mutant) recombinant antibody is suitable for IHC staining and WB.
Literature
Flyer - Angiogenesis
Download the latest version of GeneTex's Angiogenesis flyer.
Literature
Flyer-Zika Virus Research
Download the latest version of GeneTex's Zika Virus Research flyer.
Pathways
Epithelial–mesenchymal transition (EMT) Pathway
EMT is a process whereby tightly-interacting and immotile epithelial cells acquire the phenotype of loosely-adherent and motile mesenchymal cells.
Literature
Flyer - Cited Antibodies
Download the latest version of GeneTex's cited antibodies flyer.
Newsletter
A Cancer Immunotherapy Holy Grail?
A Cancer Immunotherapy Holy Grail?
Newsletter
A Well-Cited Nrf2 Antibody for Cellular Redox Research
A quality Nrf2 antibody with multiple species reactivity for cellular redox research
Newsletter
Improving cancer immunotherapy efficacy may depend on targeting exosomes
Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1
Literature
Brochure - World Class Validated Antibodies
Download the latest version of GeneTex's World Class Validated Antibodies brochure.
Literature
Poster - Cancer Signaling
Download the latest version of GeneTex's cancer signaling poster
Literature
Pamphlet - Antibodies for Cancer Research
Download the latest version of GeneTex's pamphlet of antibodies for cancer research
Literature
Flyer - EGFR Signaling
Download the latest version of GeneTex's EGFR signaling flyer.
Literature
Flyer - Epithelial–Mesenchymal Transition
Download the latest version of GeneTex's epithelial–mesenchymal transition flyer.
Literature
Flyer - Cancer Stem Cells
Download the latest version of GeneTex's cancer stem cells flyer.
Literature
Flyer - Metabolic Pathways
Download the latest version of GeneTex's metabolic pathways flyer.
Literature
Flyer - RNA-binding Proteins
Download the latest version of GeneTex's RNA-binding proteins flyer.
Literature
Flyer - DNA Damage and Repair
Download the latest version of GeneTex's DNA damage and repair flyer
Literature
Pamphlet - Hot Products
Download the latest version of GeneTex's pamphlet of hot products.
Literature
Flyer - Cancer Immune Checkpoints
Download the latest version of GeneTex's cancer immune checkpoint flyer
![GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]](/upload/website/marketing_material/list_image/genetex_20200212_KRAS_slide_255x170_20021120_758.jpg "GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]")
